SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-012595
Filing Date
2021-09-17
Accepted
2021-09-17 16:01:52
Documents
13
Period of Report
2021-09-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210916x8k.htm   iXBRL 8-K 36634
  Complete submission text file 0001558370-21-012595.txt   192514

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20210916.xsd EX-101.SCH 3389
3 EX-101.DEF tmb-20210916_def.xml EX-101.DEF 13344
4 EX-101.LAB tmb-20210916_lab.xml EX-101.LAB 20696
5 EX-101.PRE tmb-20210916_pre.xml EX-101.PRE 14211
6 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210916x8k_htm.xml XML 6955
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 211260364
SIC: 2834 Pharmaceutical Preparations